Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants.

Proceedings of the National Academy of Sciences of the United States of America
Haiyan WuJonathan M Backer

Abstract

We previously proposed a model of Class IA PI3K regulation in which p85 inhibition of p110alpha requires (i) an inhibitory contact between the p85 nSH2 domain and the p110alpha helical domain, and (ii) a contact between the p85 nSH2 and iSH2 domains that orients the nSH2 so as to inhibit p110alpha. We proposed that oncogenic truncations of p85 fail to inhibit p110 due to a loss of the iSH2-nSH2 contact. However, we now find that within the context of a minimal regulatory fragment of p85 (the nSH2-iSH2 fragment, termed p85ni), the nSH2 domain rotates much more freely (tau(c) approximately 12.7 ns) than it could if it were interacting rigidly with the iSH2 domain. These data are not compatible with our previous model. We therefore tested an alternative model in which oncogenic p85 truncations destabilize an interface between the p110alpha C2 domain (residue N345) and the p85 iSH2 domain (residues D560 and N564). p85ni-D560K/N564K shows reduced inhibition of p110alpha, similar to the truncated p85ni-572(STOP). Conversely, wild-type p85ni poorly inhibits p110alphaN345K. Strikingly, the p110alphaN345K mutant is inhibited to the same extent by the wild-type or truncated p85ni, suggesting that mutation of p110alpha-N345 is not additiv...Continue Reading

References

Sep 1, 1994·Current Biology : CB·T KodakiP J Parker
Nov 1, 1995·Journal of Biomolecular NMR·F DelaglioA Bax
Apr 5, 1996·Journal of Molecular Biology·J LiangJ Clardy
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·A MusacchioS C Harrison
Mar 24, 2000·Journal of Magnetic Resonance·G ZhuK H Sze
Apr 7, 2000·Protein Science : a Publication of the Protein Society·R O'BrienJ E Ladbury
Jun 8, 2001·Annual Review of Biochemistry·B VanhaesebroeckM D Waterfield
Nov 5, 2002·Journal of Cell Science·Vera DesMaraisSarah E Hitchcock-DeGregori
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Zheng FuGary J Gerfen
Mar 16, 2004·Science·Yardena SamuelsVictor E Velculescu
Aug 20, 2004·Methods in Molecular Biology·Bruce A Johnson
Nov 16, 2004·Archives of Biochemistry and Biophysics·Zheng FuJonathan M Backer
Jun 4, 2005·The Journal of Biological Chemistry·S Chandra ShekarJonathan M Backer
Jul 19, 2006·Nature Reviews. Genetics·Jeffrey A EngelmanLewis C Cantley
Mar 21, 2007·Biochemical Society Transactions·H WuJ M Backer
Mar 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Marco GymnopoulosPeter K Vogt
Feb 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Li Zhao, Peter K Vogt
Sep 6, 2008·Science·D Williams ParsonsKenneth W Kinzler
Sep 6, 2008·Nature·UNKNOWN Cancer Genome Atlas Research Network

❮ Previous
Next ❯

Citations

Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Minghao SunPeter K Vogt
Sep 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·John E BurkeRoger L Williams
Oct 20, 2011·Science Signaling·Oscar VadasRoger L Williams
Dec 25, 2013·PloS One·Rebecca L RossMargaret A Knowles
Feb 1, 2014·Nature Reviews. Drug Discovery·David A Fruman, Christian Rommel
Oct 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Hashem A DboukJonathan M Backer
Jan 22, 2013·Annual Review of Immunology·Klaus Okkenhaug
Sep 2, 2010·The Journal of Cell Biology·Hung-Hsiang Huang, Pamela Stanley
Jan 26, 2016·Pharmacogenomics·Lydia Wt Cheung, Gordon B Mills
Jan 23, 2016·Journal of Receptor and Signal Transduction Research·Aravind SettiSmita C Pawar
Nov 8, 2011·The Biochemical Journal·Aliaksei ShymanetsBernd Nürnberg
Jun 6, 2014·Annals of Medicine·Miriam MartiniEmilio Hirsch
Nov 12, 2014·Proceedings of the National Academy of Sciences of the United States of America·Yoshihiro ItoPeter K Vogt
Jun 5, 2008·Current Biology : CB·Len StephensPhillip Hawkins
Jun 13, 2015·BMC Complementary and Alternative Medicine·Ye HeXuezhen Hu
Nov 15, 2016·Oncogene·V TakiarL W T Cheung
Jan 3, 2019·Endocrinology·Anne R Bresnick, Jonathan M Backer
Jan 20, 2019·The Journal of Biological Chemistry·Samantha D HeitzJonathan M Backer
Dec 24, 2014·Nature Reviews. Cancer·Lauren M ThorpeJean J Zhao
Aug 1, 2013·Physiological Reviews·Tamas Balla
Sep 26, 2015·Current Opinion in Allergy and Clinical Immunology·Swadhinya Arjunaraja, Andrew L Snow
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Zhao ZhangBruce Beutler
Aug 12, 2014·Oncotarget·Michelle S MillerSandra B Gabelli
Jun 15, 2013·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Rachel Schnur Salamon, Jonathan M Backer
Sep 26, 2020·Cell Death & Disease·Qianzhi ChenYongdong Feng
Jan 25, 2014·Cancer Research·Shujuan LiuAhmed Ashour Ahmed
Oct 14, 2020·Cancer Research·Mingzhen ZhangRuth Nussinov
Nov 6, 2020·International Journal of Molecular Sciences·Kasturi RangannaZivar Yousefipour
Aug 10, 2020·Computers in Biology and Medicine·Sherlyn Jemimah, M Michael Gromiha
Dec 9, 2020·Molecular Cancer Research : MCR·Ruth NussinovHyunbum Jang
Sep 12, 2021·Proceedings of the National Academy of Sciences of the United States of America·Xinran LiLydia W T Cheung

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.